$DX
DYNEX CAPITAL INC Stock $dx

$dx Overview Financials Valuation SEC Filings Company Website

2017 Q3 Form 10-Q Financial Statement

#000082667517000038 Filed on August 08, 2017

Income Statement

Concept	2017 Q3	2017 Q2	2016 Q2
Revenue	$23.10M	$24.90M	$22.80M
YoY Change	9.48%	9.21%	-6.94%
Cost Of Revenue	$9.900M	$8.700M	$6.100M
YoY Change	62.3%	42.62%	10.91%
Gross Profit	$13.20M	$16.10M	$16.70M
YoY Change	-12.58%	-3.59%	-12.11%
Gross Profit Margin	57.14%	64.66%	73.25%
Selling, General & Admin	$3.600M	$4.100M	$3.700M
YoY Change	5.88%	10.81%	-22.92%
% of Gross Profit	27.27%	25.47%	22.16%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$300.0K	$400.0K	$400.0K
YoY Change	0.0%	0.0%	-69.23%
% of Gross Profit	2.27%	2.48%	2.4%
Operating Expenses	$3.700M	$4.100M	$3.300M
YoY Change	37.04%	24.24%	-32.65%
Operating Profit	$9.500M	$12.00M	$13.40M
YoY Change	-23.39%	-10.45%	-4.96%
Interest Expense	$9.889M	$8.714M	$6.100M
YoY Change	62.97%	42.85%	10.07%
% of Operating Profit	104.09%	72.62%	45.52%
Other Income/Expense, Net	-$109.0K	$4.000K	$318.0K
YoY Change	-118.83%	-98.74%	-49.68%
Pretax Income	$10.30M	-$7.400M	-$3.200M
YoY Change	-29.93%	131.25%	-110.49%
Income Tax
% Of Pretax Income
Net Earnings	$10.31M	-$7.432M	-$3.231M
YoY Change	-29.86%	130.02%	-110.61%
Net Earnings / Revenue	44.64%	-29.85%	-14.17%
Basic Earnings Per Share
Diluted Earnings Per Share	$620.5K	-$451.2K	-$195.1K
COMMON SHARES
Basic Shares Outstanding	49.23M shares	49.20M shares	49.10M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2017 Q3	2017 Q2	2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$117.7M	$100.9M	$96.90M
YoY Change	60.35%	4.13%	71.5%
Cash & Equivalents	$117.7M	$100.9M	$96.90M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$36.10M	$25.10M	$27.40M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$153.8M	$126.0M	$124.3M
YoY Change	50.05%	1.37%	-32.67%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$2.938B	$2.881B	$0.00
YoY Change			-100.0%
Other Assets	$44.00M	$45.40M	$83.70M
YoY Change	-48.05%	-45.76%	44.56%
Total Long-Term Assets	$2.989B	$2.934B	$3.345B
YoY Change	-7.76%	-12.27%	-16.05%
TOTAL ASSETS
Total Short-Term Assets	$153.8M	$126.0M	$124.3M
Total Long-Term Assets	$2.989B	$2.934B	$3.345B
Total Assets	$3.143B	$3.060B	$3.469B
YoY Change	-5.99%	-11.79%	-16.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$2.700M	$1.500M	$1.700M
YoY Change	22.73%	-11.76%	-19.05%
Deferred Revenue
YoY Change
Short-Term Debt	$2.519B	$2.541B	$2.864B
YoY Change	-8.1%	-11.27%	-18.44%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.611B	$2.553B	$2.878B
YoY Change	-5.26%	-11.26%	-18.53%
LONG-TERM LIABILITIES
Long-Term Debt	$5.700M	$5.900M	$7.500M
YoY Change	-18.57%	-21.33%	-14.77%
Other Long-Term Liabilities	$2.500M	$3.600M	$92.60M
YoY Change	-97.09%	-96.11%	74.72%
Total Long-Term Liabilities	$8.200M	$9.500M	$100.1M
YoY Change	-91.17%	-90.51%	61.97%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.611B	$2.553B	$2.878B
Total Long-Term Liabilities	$8.200M	$9.500M	$100.1M
Total Liabilities	$2.619B	$2.563B	$2.978B
YoY Change	-8.06%	-13.92%	-17.15%
SHAREHOLDERS EQUITY
Retained Earnings	-$361.0M	-$359.2M	-$396.6M
YoY Change	-8.5%	-9.42%	33.14%
Common Stock	$742.8M	$728.1M	$726.6M
YoY Change	2.15%	0.22%	-4.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$524.1M	$497.3M	$491.5M
YoY Change
Total Liabilities & Shareholders Equity	$3.143B	$3.060B	$3.469B
YoY Change	-5.99%	-11.79%	-16.79%

Cashflow Statement

Concept	2017 Q3	2017 Q2	2016 Q2
OPERATING ACTIVITIES
Net Income	$10.31M	-$7.432M	-$3.231M
YoY Change	-29.86%	130.02%	-110.61%
Depreciation, Depletion And Amortization	$300.0K	$400.0K	$400.0K
YoY Change	0.0%	0.0%	-69.23%
Cash From Operating Activities	$53.10M	$55.90M	$52.60M
YoY Change	3.31%	6.27%	-8.36%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$26.30M	$275.5M	$92.90M
YoY Change	-142.83%	196.56%	-126.52%
Cash From Investing Activities	-$26.30M	$275.5M	$92.90M
YoY Change	-142.83%	196.56%	-126.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-11.30M	-286.0M	-131.6M
YoY Change	-91.71%	117.33%	-142.34%
NET CHANGE
Cash From Operating Activities	53.10M	55.90M	52.60M
Cash From Investing Activities	-26.30M	275.5M	92.90M
Cash From Financing Activities	-11.30M	-286.0M	-131.6M
Net Change In Cash	15.50M	45.40M	13.90M
YoY Change	-165.96%	226.62%	-22.35%
FREE CASH FLOW
Cash From Operating Activities	$53.10M	$55.90M	$52.60M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	93000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Period End Date DocumentPeriodEndDate	2017-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000826675
CY2017Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	49234232	shares
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2016Q2	dei	Entity Public Float EntityPublicFloat	310217722	USD
	dei	Entity Registrant Name EntityRegistrantName	DYNEX CAPITAL INC
	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2016Q4	dx	Derivative Average Fixed Interest Rate Current Effective DerivativeAverageFixedInterestRateCurrentEffective	0.0073
CY2017Q2	dx	Derivative Average Fixed Interest Rate Current Effective DerivativeAverageFixedInterestRateCurrentEffective	0.0131
CY2016Q4	dx	Investments Unamortized Premium Discount InvestmentsUnamortizedPremiumDiscount	822084000	USD
CY2017Q2	dx	Investments Unamortized Premium Discount InvestmentsUnamortizedPremiumDiscount	791190000	USD
CY2017Q2	dx	Number Of Counterparties Borrowing Availability NumberOfCounterpartiesBorrowingAvailability	34	Agreements
CY2017Q2	dx	Number Of Counterparties Borrowings Outstanding NumberOfCounterpartiesBorrowingsOutstanding	18	Agreements
CY2016Q4	invest	Derivative Notional Amount DerivativeNotionalAmount	3030000000	USD
CY2017Q2	invest	Derivative Notional Amount DerivativeNotionalAmount	5285000000	USD
CY2017Q2	us-gaap	Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Net Of Tax AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax	499000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-32609000	USD
CY2017Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-257000	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	727369000	USD
CY2017Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	728124000	USD
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	73597000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	52000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	485000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	521000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-42000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	4970000	USD
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	81188000	USD
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	521000	USD
CY2016Q4	us-gaap	Assets Assets	3397731000	USD
CY2017Q2	us-gaap	Assets Assets	3060220000	USD
CY2016Q4	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	3240618000	USD
CY2017Q2	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	2864293000	USD
CY2016Q4	us-gaap	Assets Sold Under Agreements To Repurchase Interest Rate AssetsSoldUnderAgreementsToRepurchaseInterestRate	0.0103
CY2017Q2	us-gaap	Assets Sold Under Agreements To Repurchase Interest Rate AssetsSoldUnderAgreementsToRepurchaseInterestRate	0.0147
CY2016Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	19643000	USD
CY2017Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	23431000	USD
CY2016Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	52526000	USD
CY2017Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	23882000	USD
CY2016Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	3244967000	USD
CY2017Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	2864477000	USD
CY2016Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	3212084000	USD
CY2017Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	2864026000	USD
CY2016Q2	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	-297000	USD
	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	-4238000	USD
CY2017Q2	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	3709000	USD
	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	-5417000	USD
CY2016Q2	us-gaap	Available For Sale Securities Gross Realized Gains Losses Sale Proceeds AvailableForSaleSecuritiesGrossRealizedGainsLossesSaleProceeds	10287000	USD
	us-gaap	Available For Sale Securities Gross Realized Gains Losses Sale Proceeds AvailableForSaleSecuritiesGrossRealizedGainsLossesSaleProceeds	87818000	USD
CY2017Q2	us-gaap	Available For Sale Securities Gross Realized Gains Losses Sale Proceeds AvailableForSaleSecuritiesGrossRealizedGainsLossesSaleProceeds	342310000	USD
	us-gaap	Available For Sale Securities Gross Realized Gains Losses Sale Proceeds AvailableForSaleSecuritiesGrossRealizedGainsLossesSaleProceeds	399474000	USD
	us-gaap	Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments	-4238000	USD
	us-gaap	Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments	-5417000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33935000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	96897000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	74120000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	100863000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	62962000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	26743000	USD
CY2017Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.18
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2017Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49153463	shares
CY2017Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49234493	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49153463	shares
CY2017Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49234493	shares
CY2016Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	492000	USD
CY2017Q2	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	492000	USD
CY2016Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	17422000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	19426000	USD
CY2017Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2302000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	28894000	USD
CY2016Q4	us-gaap	Derivative Assets DerivativeAssets	28534000	USD
CY2017Q2	us-gaap	Derivative Assets DerivativeAssets	267000	USD
CY2016Q4	us-gaap	Derivative Average Fixed Interest Rate DerivativeAverageFixedInterestRate	0.0158
CY2017Q2	us-gaap	Derivative Average Fixed Interest Rate DerivativeAverageFixedInterestRate	0.0167
CY2016	us-gaap	Derivative Average Remaining Maturity1 DerivativeAverageRemainingMaturity1	P5Y3M18D
	us-gaap	Derivative Average Remaining Maturity1 DerivativeAverageRemainingMaturity1	P3Y4M13D
CY2016Q4	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	22085000	USD
CY2017Q2	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	0	USD
CY2016Q4	us-gaap	Derivative Collateral Obligation To Return Securities DerivativeCollateralObligationToReturnSecurities	6449000	USD
CY2017Q2	us-gaap	Derivative Collateral Obligation To Return Securities DerivativeCollateralObligationToReturnSecurities	4000	USD
CY2016Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	0	USD
CY2017Q2	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	961000	USD
CY2016Q4	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	6913000	USD
CY2017Q2	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	18000	USD
CY2016Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	28534000	USD
CY2017Q2	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	267000	USD
CY2016Q4	us-gaap	Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral	28534000	USD
CY2017Q2	us-gaap	Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral	267000	USD
CY2016Q4	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	0	USD
CY2017Q2	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	263000	USD
CY2016Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	6922000	USD
CY2017Q2	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	1686000	USD
CY2016Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral	6922000	USD
CY2017Q2	us-gaap	Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral	1686000	USD
CY2016Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral	9000	USD
CY2017Q2	us-gaap	Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral	707000	USD
CY2016Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	21612000	USD
CY2017Q2	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	249000	USD
CY2016Q4	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue	28534000	USD
CY2017Q2	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue	267000	USD
CY2016Q2	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-16297000	USD
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-64561000	USD
CY2017Q2	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-15802000	USD
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-15627000	USD
CY2016Q4	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue	6922000	USD
CY2017Q2	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue	1686000	USD
CY2016Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	6922000	USD
CY2017Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	1686000	USD
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	17718000	USD
CY2016Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	12268000	USD
CY2017Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	11121000	USD
	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	5077000	USD
CY2016Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.11
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.92
CY2017Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.20
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.07
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y7M12D
CY2017Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	1892000	USD
CY2016Q4	us-gaap	Financial Instruments Owned And Pledged As Collateral At Fair Value FinancialInstrumentsOwnedAndPledgedAsCollateralAtFairValue	3150610000	USD
CY2017Q2	us-gaap	Financial Instruments Owned And Pledged As Collateral At Fair Value FinancialInstrumentsOwnedAndPledgedAsCollateralAtFairValue	2743850000	USD
CY2016Q4	us-gaap	Financial Instruments Owned Mortgages Mortgage Backed And Asset Backed Securities At Fair Value FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue	3212084000	USD
CY2017Q2	us-gaap	Financial Instruments Owned Mortgages Mortgage Backed And Asset Backed Securities At Fair Value FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue	2864026000	USD
CY2016Q2	us-gaap	Gain Loss On Sales Of Mortgage Backed Securities Mbs GainLossOnSalesOfMortgageBackedSecuritiesMBS	-297000	USD
	us-gaap	Gain Loss On Sales Of Mortgage Backed Securities Mbs GainLossOnSalesOfMortgageBackedSecuritiesMBS	-4238000	USD
CY2017Q2	us-gaap	Gain Loss On Sales Of Mortgage Backed Securities Mbs GainLossOnSalesOfMortgageBackedSecuritiesMBS	-3709000	USD
	us-gaap	Gain Loss On Sales Of Mortgage Backed Securities Mbs GainLossOnSalesOfMortgageBackedSecuritiesMBS	-5417000	USD
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-3145000	USD
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-1101000	USD
	us-gaap	Increase Decrease In Financial Instruments Used In Operating Activities IncreaseDecreaseInFinancialInstrumentsUsedInOperatingActivities	-64561000	USD
	us-gaap	Increase Decrease In Financial Instruments Used In Operating Activities IncreaseDecreaseInFinancialInstrumentsUsedInOperatingActivities	-15627000	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-29000	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-1633000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	881000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	2120000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	32489000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	20608000	USD
CY2016Q2	us-gaap	Interest Expense InterestExpense	6100000	USD
	us-gaap	Interest Expense InterestExpense	12410000	USD
CY2017Q2	us-gaap	Interest Expense InterestExpense	8714000	USD
	us-gaap	Interest Expense InterestExpense	16233000	USD
CY2016Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	16716000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	35495000	USD
CY2017Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	16142000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	31042000	USD
CY2016Q2	us-gaap	Interest Income Operating InterestIncomeOperating	22816000	USD
	us-gaap	Interest Income Operating InterestIncomeOperating	47905000	USD
CY2017Q2	us-gaap	Interest Income Operating InterestIncomeOperating	24856000	USD
	us-gaap	Interest Income Operating InterestIncomeOperating	47275000	USD
	us-gaap	Interest Paid InterestPaid	12476000	USD
	us-gaap	Interest Paid InterestPaid	18029000	USD
CY2016Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	3156000	USD
CY2017Q2	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	1524000	USD
CY2016Q4	us-gaap	Interest Receivable InterestReceivable	20396000	USD
CY2017Q2	us-gaap	Interest Receivable InterestReceivable	19295000	USD
CY2016Q4	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	2422883000	USD
CY2017Q2	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	2073287000	USD
CY2016Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1875000	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	4093000	USD
CY2017Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2041000	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	4286000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	2930547000	USD
CY2017Q2	us-gaap	Liabilities Liabilities	2562945000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3397731000	USD
CY2017Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3060220000	USD
CY2016Q4	us-gaap	Liabilities Fair Value Disclosure Recurring LiabilitiesFairValueDisclosureRecurring	6922000	USD
CY2017Q2	us-gaap	Liabilities Fair Value Disclosure Recurring LiabilitiesFairValueDisclosureRecurring	1686000	USD
CY2017Q2	us-gaap	Line Of Credit LineOfCredit	359263000	USD
CY2017Q2	us-gaap	Line Of Credit Facility Interest Rate At Period End LineOfCreditFacilityInterestRateAtPeriodEnd	0.0209
CY2016Q4	us-gaap	Other Receivables From Broker Dealers And Clearing Organizations OtherReceivablesFromBrokerDealersAndClearingOrganizations	11978000	USD
CY2017Q2	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	400000000	USD
CY2016Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	19036000	USD
CY2017Q2	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	17345000	USD
CY2016Q4	us-gaap	Long Term Debt LongTermDebt	6440000	USD
CY2017Q2	us-gaap	Long Term Debt LongTermDebt	5892000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-306756000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-385522000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	263507000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	309245000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	106211000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	103020000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-3231000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-40662000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	-7432000	USD
	us-gaap	Net Income Loss NetIncomeLoss	1619000	USD
CY2016Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5525000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-45250000	USD
CY2017Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10073000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3458000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	22947000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	64676000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	12375000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	32352000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-297000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-4238000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-3709000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-5417000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	80000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	53000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	73000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	172000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	22730000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	60491000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	8739000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	27107000	USD
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	850000	USD
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	682000	USD
CY2016Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1796000	USD
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	3669000	USD
CY2017Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	2056000	USD
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	4091000	USD
CY2016Q4	us-gaap	Other Liabilities OtherLiabilities	2809000	USD
CY2017Q2	us-gaap	Other Liabilities OtherLiabilities	1963000	USD
CY2016Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	290000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	353000	USD
CY2017Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4000	USD
CY2017Q2	us-gaap	Other Receivables From Broker Dealers And Clearing Organizations OtherReceivablesFromBrokerDealersAndClearingOrganizations	5812000	USD
	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	26092000	USD
	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	-7405000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	55000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	212000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	310000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	26670000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	23942000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	282943000	USD
CY2016Q4	us-gaap	Pledged Financial Instruments Not Separately Reported Securities For Repurchase Agreements PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesForRepurchaseAgreements	3149839000	USD
CY2017Q2	us-gaap	Pledged Financial Instruments Not Separately Reported Securities For Repurchase Agreements PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesForRepurchaseAgreements	2747457000	USD
	us-gaap	Preferred Stock Dividend Payment Terms PreferredStockDividendPaymentTerms	The Series A Preferred Stock pays a cumulative cash dividend equivalent to 8.50% of the $25.00 liquidation preference per share each year and the Series B Preferred Stock pays a cumulative cash dividend equivalent to 7.625% of the $25.00 liquidation preference per share each year.
CY2016Q2	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2294000	USD
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	4588000	USD
CY2017Q2	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2641000	USD
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	5077000	USD
CY2017Q2	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	25.00
CY2016Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	114298000	USD
CY2017Q2	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	133716000	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2017Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2017Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	4571937	shares
CY2017Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	5348658	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	4571937	shares
CY2017Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	5348658	shares
CY2016Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	110005000	USD
CY2017Q2	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	128165000	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	6814000	USD
CY2017Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	7235000	USD
	us-gaap	Proceeds From Collection Of Finance Receivables ProceedsFromCollectionOfFinanceReceivables	2319000	USD
	us-gaap	Proceeds From Collection Of Finance Receivables ProceedsFromCollectionOfFinanceReceivables	1876000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	77000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	139000	USD
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	11394652000	USD
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	39007126000	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	18212000	USD
	us-gaap	Proceeds From Limited Partnership Investments ProceedsFromLimitedPartnershipInvestments	10835000	USD
	us-gaap	Proceeds From Limited Partnership Investments ProceedsFromLimitedPartnershipInvestments	0	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	187437000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	183636000	USD
	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	-939000	USD
	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	-557000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	94033000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	399483000	USD
	us-gaap	Profit Loss ProfitLoss	-40662000	USD
	us-gaap	Profit Loss ProfitLoss	1619000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	11640592000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	39365319000	USD
	us-gaap	Repurchase Agreement Counterparty Weighted Average Maturity Of Agreements1 RepurchaseAgreementCounterpartyWeightedAverageMaturityOfAgreements1	P20D
	us-gaap	Repurchase Agreement Counterparty Weighted Average Maturity Of Agreements1 RepurchaseAgreementCounterpartyWeightedAverageMaturityOfAgreements1	P19D
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	24769000	USD
CY2017Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	45377000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-338073000	USD
CY2017Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-359249000	USD
CY2016Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	2898952000	USD
CY2017Q2	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	2540759000	USD
CY2016Q4	us-gaap	Securities Sold Under Agreements To Repurchase Amount Offset Against Collateral SecuritiesSoldUnderAgreementsToRepurchaseAmountOffsetAgainstCollateral	0	USD
CY2017Q2	us-gaap	Securities Sold Under Agreements To Repurchase Amount Offset Against Collateral SecuritiesSoldUnderAgreementsToRepurchaseAmountOffsetAgainstCollateral	0	USD
CY2016Q4	us-gaap	Securities Sold Under Agreements To Repurchase Asset SecuritiesSoldUnderAgreementsToRepurchaseAsset	0	USD
CY2017Q2	us-gaap	Securities Sold Under Agreements To Repurchase Asset SecuritiesSoldUnderAgreementsToRepurchaseAsset	0	USD
CY2016Q4	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Cash SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimCash	0	USD
CY2017Q2	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Cash SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimCash	0	USD
CY2016Q4	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Securities SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimSecurities	2898952000	USD
CY2017Q2	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Securities SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimSecurities	2540759000	USD
CY2016Q4	us-gaap	Securities Sold Under Agreements To Repurchase Gross SecuritiesSoldUnderAgreementsToRepurchaseGross	2898952000	USD
CY2017Q2	us-gaap	Securities Sold Under Agreements To Repurchase Gross SecuritiesSoldUnderAgreementsToRepurchaseGross	2540759000	USD
CY2016Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1443000	USD
CY2017Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1179000	USD
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	46158	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	214878	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	29720	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	138166	shares
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.50
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.28
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.73
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.76
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	696597	shares
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	547486	shares
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	561089	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	553396	shares
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	386151	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	353103	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	8.54
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	7.63
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	7.54
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	7.55
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	7.05
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	7.01
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	32555	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	350386	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	62768	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	338459	shares
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	7.68
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	8.76
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	7.14
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	7.80
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	2500000	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	785962	shares
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	18351000	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	1178000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	467184000	USD
CY2017Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	497275000	USD
CY2016Q2	us-gaap	Trading Securities Unrealized Holding Gain Loss TradingSecuritiesUnrealizedHoldingGainLoss	28000	USD
	us-gaap	Trading Securities Unrealized Holding Gain Loss TradingSecuritiesUnrealizedHoldingGainLoss	51000	USD
CY2017Q2	us-gaap	Trading Securities Unrealized Holding Gain Loss TradingSecuritiesUnrealizedHoldingGainLoss	30000	USD
	us-gaap	Trading Securities Unrealized Holding Gain Loss TradingSecuritiesUnrealizedHoldingGainLoss	40000	USD
CY2016Q4	us-gaap	Transfers Accounted For As Secured Borrowings Associated Liabilities Carrying Amount TransfersAccountedForAsSecuredBorrowingsAssociatedLiabilitiesCarryingAmount	2898952000	USD
CY2017Q2	us-gaap	Transfers Accounted For As Secured Borrowings Associated Liabilities Carrying Amount TransfersAccountedForAsSecuredBorrowingsAssociatedLiabilitiesCarryingAmount	2540759000	USD
CY2016Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	49119000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	49080000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	49218000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	49197000	shares
	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recent Accounting Pronouncements</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2017-08, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Receivables-Nonrefundable Fees and Other Costs, </font><font style="font-family:inherit;font-size:10pt;">which shortens the amortization period for certain callable debt securities held at a premium, requiring the premium to be amortized to the earliest call date. The amendments in this ASU are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018 and early adoption is permitted. The amendments in this Update should be applied using the modified-retrospective transition approach and will require disclosures for the change in accounting principle. The Company is currently evaluating the impact of this ASU on its consolidated financial statements.</font></div></div>
	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Organization</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dynex Capital, Inc., ("Company") was incorporated in the Commonwealth of Virginia on December 18, 1987 and commenced operations in February 1988. The Company primarily earns income from investing on a leveraged basis in Agency and non-Agency mortgage-backed securities (“MBS”) consisting of residential MBS (“RMBS”), commercial MBS (“CMBS”) and CMBS interest-only ("IO") securities that are issued or guaranteed by the U.S. Government or U.S. Government sponsored agencies ("Agency MBS") and MBS issued by others ("non-Agency MBS"). We may also invest in other types of mortgage-related securities, such as to-be-announced (“TBA”) forward contracts for the purchase or sale of generic Agency MBS.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>
	us-gaap	Reclassifications Reclassifications	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Reclassifications</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain items in the prior periods' consolidated financial statements have been reclassified to conform to the current period's presentation. The Company has reclassified amortization of stock issuance costs which was previously recorded in "proceeds from issuance of common stock, net of issuance costs" in the financing activities section of the Company's consolidated statements of cash flows for </font><font style="font-family:inherit;font-size:10pt;">six months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">June 30, 2016</font><font style="font-family:inherit;font-size:10pt;">. Amortization of stock issuance costs is now presented within "other operating activities" in the operating activities section of the Company's consolidated statements of cash flows. This presentation change had no effect on reported financial condition or results of operations and did not have a material impact on cash flows from operating or financing activities.</font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported amounts of revenue and expenses during the reported period. Actual results could differ from those estimates. The most significant estimates used by management include, but are not limited to, amortization of premiums and discounts, fair value measurements of its investments, and other-than-temporary impairments. These items are discussed further below within this note to the consolidated financial statements.</font></div><div style="line-height:120%;text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></div>

Files In Submission

Name	View Source	Status
0000826675-17-000038-index-headers.html	Edgar Link	pending
0000826675-17-000038-index.html	Edgar Link	pending
0000826675-17-000038.txt	Edgar Link	pending
0000826675-17-000038-xbrl.zip	Edgar Link	pending
a1q17form10-_chartx17331a01.jpg	Edgar Link	pending
a1q17form10-_chartx19534a01.jpg	Edgar Link	pending
a1q17form10-_chartx19947a01.jpg	Edgar Link	pending
a1q17form10-_chartx25643a01.jpg	Edgar Link	pending
a1q17form10-_chartx26682a01.jpg	Edgar Link	pending
a1q17form10-_chartx27774a01.jpg	Edgar Link	pending
a1q17form10-_chartx28759a01.jpg	Edgar Link	pending
a1q17form10-_chartx30150a01.jpg	Edgar Link	pending
a1q17form10-_chartx32398a01.jpg	Edgar Link	pending
a2q17form10-q.htm	Edgar Link	pending
a2q17form10-qexx1018direct.htm	Edgar Link	pending
a2q17form10-qexx121ratioof.htm	Edgar Link	pending
a2q17form10-qexx311ceocert.htm	Edgar Link	pending
a2q17form10-qexx312cfocert.htm	Edgar Link	pending
a2q17form10-qexx321soxcert.htm	Edgar Link	pending
a2q17form10-qexx32amendedb.htm	Edgar Link	pending
dx-20170630.xml	Edgar Link	completed
dx-20170630.xsd	Edgar Link	pending
dx-20170630_cal.xml	Edgar Link	unprocessable
dx-20170630_def.xml	Edgar Link	unprocessable
dx-20170630_lab.xml	Edgar Link	unprocessable
dx-20170630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DX
DYNEX CAPITAL INC Stock $dx

2017 Q3 Form 10-Q Financial Statement

#000082667517000038 Filed on August 08, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DX DYNEX CAPITAL INC Stock $dx

2017 Q3 Form 10-Q Financial Statement

#000082667517000038 Filed on August 08, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DX
DYNEX CAPITAL INC Stock $dx